# Adrenaline for the Treatment of No-Reflow in Normotensive Patients

> **NCT04699110** · PHASE4 · COMPLETED · sponsor: **National Institute of Cardiovascular Diseases, Pakistan** · enrollment: 201 (actual)

## Conditions studied

- Acute Coronary Syndrome
- No-Reflow Phenomenon
- Normotensive

## Interventions

- **DRUG:** Adrenaline
- **DRUG:** Adenosine

## Key facts

- **NCT ID:** NCT04699110
- **Lead sponsor:** National Institute of Cardiovascular Diseases, Pakistan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-01
- **Primary completion:** 2021-04-30
- **Final completion:** 2021-04-30
- **Target enrollment:** 201 (ACTUAL)
- **Last updated:** 2021-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04699110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04699110, "Adrenaline for the Treatment of No-Reflow in Normotensive Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04699110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*